Global healthcare company Novo Nordisk has been selected to appear in a forthcoming digital publication entitled Cambridge Strategies, which will showcase leading educational institutions and top employers from around the world. Cambridge Strategies will provide insights into today’s ever-changing professional and academic landscapes.
Going live in February 2016 and published by Cambridge University Students’ Union (CUSU) and its official publisher, St James’s House, Cambridge Strategies will include an eBook, website, app and marketing campaign aimed at high-calibre students.
“Cambridge Strategies is a groundbreaking global campaign that will deliver thought-provoking content in an interactive and user-friendly format,” says Richard Freed, Chief Executive of St James’s House. “The website will not only identify leaders in education and an extensive range of professional opportunities, but will also provide a digital platform for discussing some of the most pressing issues within education and employment – such as the increasing need for digital skills.”
The inclusion of Novo Nordisk will provide the project with invaluable insight. Founded in 1923 by Nobel Prize-winner August Krogh, Novo Nordisk is today responsible for around half of the world’s insulin production, and more than 24 million people around the world are treated with insulin from Novo Nordisk every day. Expanding still, the healthcare leader has more than 7,000 employees working in research and development around the world and offers a host of exciting graduate training programmes, postdoctoral fellowships and postgraduate research opportunities. Novo Nordisk aims to add an additional 3,000 research and development talents by 2023.
“Young graduates in today’s natural and medical sciences are very demanding of their employers – and they should be. What is particularly important for a young person is to feel that he or she is appreciated, and can advance and have exciting opportunities – and you need to be in a growing company to accomplish that,” says Mads Krogsgaard Thomsen, executive vice president and chief science officer of Novo Nordisk. “It should be attractive for young Cambridge scholars to come to us and for us to employ them.”
A truly international project, Cambridge Strategies will engage with an informed and influential audience of global talent, including the University of Cambridge’s 22,000 students, members of the Cambridge Alumni Association, more than 50,000 educational institutions from over 190 countries and the senior management of companies on all the major global indices.
The Cambridge Strategies eBook and app can be accessed via the project’s website at www.cambridge-strategies.org